India on Monday, 17 May, reported 2,81,386 new COVID-19 cases, 3,78,741 discharges, and 4,106 deaths, as per the Union Health Ministry. The total cases in the country now stands at 2,49,65,463, while the death toll is at 2,74,390.
Meanwhile, the use of convalescent plasma for treating COVID-19 patients has been dropped from the Clinical Management Guidelines, the Indian Council of Medical Research (ICMR) said on Monday.
- PM Narendra Modi on Monday interacted with doctors from across the country on their learnings and suggestions regarding COVID-19
- Maharashtra on Monday reported 26,616 new coronavirus cases and 516 deaths, taking the tally in the state to 54,05,068 and the death toll to 82,486.
- The state of Haryana extended the existing lockdown till 24 May, Health Minister Anil Vij announced
(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)
Use of Convalescent Plasma for Treating COVID Patients Dropped From Guidelines: ICMR
The use of convalescent plasma for treating COVID-19 patients has been dropped from the Clinical Management Guidelines, the Indian Council of Medical Research (ICMR) said on Monday, reported PTI.
26,616 New COVID Cases, 516 Deaths in Maharashtra
Maharashtra on Monday reported 26,616 new coronavirus cases and 516 deaths, taking the tally in the state to 54,05,068 and the death toll to 82,486.
PM Modi Interacts With Doctors on COVID-19
PM Narendra Modi on Monday interacted with doctors from across the country on their learnings and suggestions regarding COVID-19, reported PTI.
Thanking the medical fraternity for the exemplary fight in the extraordinary circumstances of the second COVID wave, PM Modi told the doctors that the strategy of starting vaccination with frontline warriors paid rich dividends in this wave, according to statement by the PM's office.
He also called upon doctors to put in extra efforts towards spreading awareness about mucormycosis.
Be it testing, supply of medicines or setting up new infrastructure, all this is being done at a fast pace, Modi reportedly said.
Shilpa Medicare Ties up With Dr Reddy’s To Produce Sputnik V Vaccine
Raichur-headquartered Shilpa Medicare has signed a three-year agreement with Dr Reddy’s to produce Sputnik V, the company announced on Monday. Shilpa Medicare’s wholly-owned subsidiary Shilpa Biologicals Private Limited (SBPL) tied up with Dr Reddy’s Laboratories (DRL) to produce the vaccine from its integrated biologics R&D cum manufacturing centre at Dharwad.